Antibiotic Prophylaxis in Urology
Autor: | Pierfrancesco Bassi, Salvatore Marco Recupero, Emilio Sacco, Marco Racioppi, Nazario Foschi, Riccardo Bientinesi |
---|---|
Rok vydání: | 2014 |
Předmět: |
Male
medicine.medical_specialty medicine.drug_class Urology Antibiotics Treatment outcome Psychological intervention MEDLINE Infezioni vie urinarie Antibiotic resistance medicine Humans Antibiotic prophylaxis Intensive care medicine High rate Settore MED/24 - UROLOGIA business.industry Transurethral Resection of Prostate General Medicine Antibiotic Prophylaxis Urological surgery Treatment Outcome Practice Guidelines as Topic Urinary Tract Infections Wound Infection Urologic Surgical Procedures Female business |
Zdroj: | Urologia Journal. 81:209-217 |
ISSN: | 1724-6075 0391-5603 |
DOI: | 10.5301/uro.5000098 |
Popis: | Introduction Antibiotic prophylaxis (AP) is used to minimize infectious complications resulting from interventions. Due to high rates of development of bacterial resistance and side effects, the use of antibiotics must be weighed on the basis of high levels of evidence. The main endpoints of urology AP are the prevention of symptomatic urogenital infections, urosepsis and wound infections. The purpose of this review is to bring objectives, principles and recommendations on urology AP according to the latest scientific evidence. Methods We carried out a systematic search of MEDLINE, EMBASE and the Cochrane Library using keywords such as AP, prophylaxis, antibiotics, urological surgery, urogenital surgery and the names of the urologic procedures. The results of studies on the AP for each procedure were classified according to the levels of evidence and grades of recommendation from the European Association of Urology. Results There are a number of good quality studies on AP about endoscopic resection of the prostate (TURP), urodynamic studies and transrectal prostate biopsies (trPB). The majority of the studies about other procedures have several limitations (sample size, consistency of definitions, statistics and trial design). Lack of consistency in the definitions of infectious complications does not allow comparison between different studies. Conclusions The AP is evidence-based is indicated only for TURP and trPB. It is desirable to perform randomized, prospective and controlled trials in order to rationalize the use of antibiotics, improve the cost/benefit ratio and reduce bacterial antibiotic resistances. |
Databáze: | OpenAIRE |
Externí odkaz: |